Correlation Between Unity Biotechnology and Black Diamond

Can any of the company-specific risk be diversified away by investing in both Unity Biotechnology and Black Diamond at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unity Biotechnology and Black Diamond into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Unity Biotechnology and Black Diamond Therapeutics, you can compare the effects of market volatilities on Unity Biotechnology and Black Diamond and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unity Biotechnology with a short position of Black Diamond. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unity Biotechnology and Black Diamond.

Diversification Opportunities for Unity Biotechnology and Black Diamond

0.47

Correlation Coefficient

Unity Biotechnology  Black Diamond

Very weak diversification

The 3 months correlation between Unity and Black is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Unity Biotechnology and Black Diamond Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Black Diamond Therap and Unity Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unity Biotechnology are associated (or correlated) with Black Diamond. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Black Diamond Therap has no effect on the direction of Unity Biotechnology i.e., Unity Biotechnology and Black Diamond go up and down completely randomly.

Pair Corralation between Unity Biotechnology and Black Diamond

Considering the 90-day investment horizon Unity Biotechnology is expected to generate 1.94 times more return on investment than Black Diamond. However, Unity Biotechnology is 1.94 times more volatile than Black Diamond Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Black Diamond Therapeutics is currently generating about -0.05 per unit of risk. If you would invest  96.00  in Unity Biotechnology on December 28, 2024 and sell it today you would earn a total of  22.00  from holding Unity Biotechnology or generate 22.92% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Unity Biotechnology  vs.  Black Diamond Therapeutics

Unity Biotechnology

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Unity Biotechnology are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent fundamental drivers, Unity Biotechnology showed solid returns over the last few months and may actually be approaching a breakup point.

Black Diamond Therap

Risk-Adjusted Performance

Very Weak

Over the last 90 days Black Diamond Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Unity Biotechnology and Black Diamond

The main advantage of trading using opposite Unity Biotechnology and Black Diamond positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unity Biotechnology position performs unexpectedly, Black Diamond can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Black Diamond will offset losses from the drop in Black Diamond's long position.

The idea behind Unity Biotechnology and Black Diamond Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.